Z-2798-2020 Class II Terminated

Recalled by Intrinsic Therapeutics, Inc. — Woburn, MA

FDA device recall Z-2798-2020 was initiated by Intrinsic Therapeutics, Inc. on Jul 24, 2020 and is designated Class II. Reason for recall: The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM. The recall status is terminated (terminated Sep 16, 2020). Affected quantity: 110 units.

Recall details

Product Type
Devices
Report Date
Aug 19, 2020
Initiation Date
Jul 24, 2020
Termination Date
Sep 16, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
110 units

Product description

Barricaid Annual Closure Device (ACD) BAR-A8-8MM - Product Usage: The Barricaid¿ ACD is indicated for reducing the incidence of reherniation, and reoperation in skeletally mature patients with radiculopathy (with or without back pain) attributed to a posterior or posterolateral herniation, and confirmed by history, physical examination and imaging studies which demonstrate neural compression using MRI to treat a large annular defect (between 4-6 mm tall and between 6-10 mm wide) following a primary discectomy procedure (excision of herniated intervertebral disc) at a single level between L4 and S1.

Reason for recall

The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM.

Distribution pattern

US Nationwide distribution.

Code information

Catalog #: BAR-A8-8MM Part #: 2730815-A8 Lot #: 06112001, 06152001

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2798-2020
openFDA file date
Nov 17, 2026
Loaded by RegDataLab
Nov 18, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2798-2020. Report a data issue: hello@regdatalab.com.